Clinical Trials Sponsored by Marco Bezzi

Total 465 results

Mario Negri Institute for Pharmacological Research
Bristol-Myers Squibb

Completed

Pragmatic RCT Comparing Aripiprazole, Olanzapine and Haloperidol in the Treatment of Schizophrenia (GiSAS)

Schizophrenia

Italy
Mario Negri Institute for Pharmacological Research
Leadiant Biosciences, Inc.

Completed

Acetyl-L-Carnitine in Type 2 Diabetes (DIABASI)

Hypertension | Diabetes Type 2

Italy
Marcos Felipe Marcatto de Abreu

Not yet recruiting

"Enhancing Surgical Safety in Developing Nations: Investigating Antibiotics' Role in Hand Surgeries."

Soft Tissue Injuries
Mario Negri Institute for Pharmacological Research
Prime Care Physicians

Not yet recruiting

Anti-inflammatory Drug Algorithm for COVID-19 Home Treatment (COVER3)

COVID-19
Mario Negri Institute for Pharmacological Research
University of Pavia

Active, not recruiting

MuLtidimensional School-based and Family interVentions to Promote hEalthy and Sustainable LifestYle for the Childhood (LIVELY)

Childhood Obesity

Italy
Mario Negri Institute for Pharmacological Research
Laminate Medical Technologies

Completed

VasQ and Hemodynamic Conditions in AVFs (RESHAPE)

Renal Insufficiency, Chronic

Italy
Italian Sarcoma Group
Istituto Di Ricerche Farmacologiche Mario Negri

Completed

Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma (TRAVELL)

Leiomyosarcoma | Liposarcoma

Italy
Marc Poulin
University of Zurich

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Sustained Attention in Lowlanders

Effect of High Altitude

Canada
Marc Suhrcke
University of Chile

Completed

Evaluation of the Impact of a Sugar-Sweetened Beverage Tax in Chile

Obesity | Chronic Disease
Marco Bueter
Dr. Alan Spector, Florida State University, Department of Psychology

Completed

Microstructure of Ingestive Behavior and Body Weight Loss After Roux-en-Y Gastric Bypass (Drinkometer)

Obesity | Bariatric Surgery | Ingestive Behavior | Food Deprivation | Roux-en-y Gastric Bypass | Ingestive Microstructure | Drinkometer

Switzerland
Marc Rothenberg, MD

Completed

A Study of Flovent in Patients With Eosinophilic Esophagitis

Eosinophilic Esophagitis

United States
Marc Poulin
University of Zurich

Completed

Effect of High Altitude Exposure, Acclimatization and Re-exposure on Psychomotor Performance in Lowlanders

Effect of High Altitude

Canada
Mario Negri Institute for Pharmacological Research
Hoffmann-La Roche

Active, not recruiting

Atezolizumab Trial in Endometrial Cancer - AtTEnd (AtTEnd)

Endometrial Cancer

New Zealand, Korea, Republic of, United Kingdom, Italy, Spain, Japan, Germany, Australia, Switzerland, Austria, Taiwan
Mario Negri Institute for Pharmacological Research
Roche Pharma AG

Active, not recruiting

Obinutuzumab in Primary MN (ORION)

Membranous Nephropathy

Italy
Istituto Clinico Humanitas
Istituto Di Ricerche Farmacologiche Mario Negri

Completed

Aging of Hematopoietic Stem Cells - Molecular Architecture of Marrow Dysplasia and Clinical Contribution of Ineffective Hematopoiesis to Frailty in the Elderly

Anemia | Clonal Hematopoiesis

Italy
Marco Leyton

Active, not recruiting

Investigation of Cigarette Cravings in Smokers

Tobacco Use | Addiction Nicotine | Cigarette Smoking

Canada
Marko Kraljevic
University Hospital, Basel, Switzerland

Recruiting

2D 4K vs. 3D HD in Bariatric Laparoscopic Surgery

Laparoscopy

Switzerland
Catherine Christie Ruiz Yasuda

Not yet recruiting

Retention of Flowable Resin With Sprg and of a Flowable Resin in First Permanent Molars

Pit and Fissure Sealant

Peru
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis (ARCADIA)

Hypertension | Left Ventricular Hypertrophy

Italy
Marcio Zaffalon Casati
Dentsply Sirona Implants and Consumables

Unknown

Prospective Observational Study of SynCone® Concept

Jaw, Edentulous

Brazil
University of Mississippi Medical Center
March of Dimes; IMPLICIT Network

Enrolling by invitation

Interconception Care at the University of Mississippi Medical Center

Depression | Maternal Behavior

United States
Mario Negri Institute for Pharmacological Research
Hoffmann-La Roche; PharmaMar

Completed

Bevacizumab and Trabectedin +/- Carboplatin in Advanced Ovarian Cancer

Ovarian Epithelial Cancer Recurrent

Italy
Marcos Vera Hernandez
Evidence Action; MaiMwana

Completed

Leveraging an Existing Large-scale Safe Water Program to Deliver Nutrition Messages at a Low Marginal Cost

Child Malnutrition

Kenya
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing ESRD in Overt Nephropathy of Type 2 Diabetes (VALID)

Diabetes

Italy, Slovenia
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

E-learning to Improve the Quality of Drug Prescribing in Hospitalized Elderly Patients

Drug Use
Mario Negri Institute for Pharmacological Research
Istituto Superiore di Sanità

Completed

Preventing Renal Functional Abnormalities With Calorie Restriction in Subjects With Abdominal Obesity and Type 2 Diabetes at Increased Renal and Cardiovascular Risk (CRESO)

Diabetes Mellitus

Italy
California State University, San Marcos
National Institutes of Health (NIH)

Unknown

Effect of Intense Multi-modal Training on Bone Health and Quality of Life in Persons With Spinal Cord Injury

Obesity | Spinal Cord Injury

United States
University of Turin, Italy
Istituto Di Ricerche Farmacologiche Mario Negri

Not yet recruiting

Preventing Cardiovascular Collapse With Vasopressors During Tracheal Intubation (PREVENTION)

Critical Illness | Respiratory Failure

France, Ireland, Italy
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Study of Clinical and Biological Prognostic Factors in Patients With Ovarian Cancer Receiving Carboplatin +Paclitaxel With Bevacizumab (MITO16/MANGO-2)

Ovarian Cancer

Italy
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Active, not recruiting

Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer (MITO16MANGO2b)

Recurrent Ovarian Cancer

France, Italy, Switzerland, Monaco, Greece
Mario Negri Institute for Pharmacological Research
Otsuka Pharmaceutical Italy S.r.l.

Completed

Tolvaptan-Octreotide LAR Combination in ADPKD (TOOL)

Autosomal Dominant Polycystic Kidney Disease

Italy
Mario Negri Institute for Pharmacological Research
PharmaMar; Averion International Corporation

Completed

INOVATYON STUDY -International, Randomized Study in Patients With Ovarian Cancer (INOVATYON)

Ovarian Cancer

Austria, Belgium, Norway, Spain, Finland, United Kingdom, Italy, Denmark, Germany, Netherlands, Switzerland
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Preventing Microalbuminuria in Type 2 Diabetes (VARIETY)

Diabetes

Italy
Mario Negri Institute for Pharmacological Research
Alexion Pharma Italy s.r.l.

Completed

Eculizumab in Primary MPGN (EAGLE)

Membranoproliferative Glomerulonephritis

Italy
University of Oldenburg
Marc Onken, M.Sc.; Christina Mueller, M.Sc.

Recruiting

Depression-Reduction by Accelerated Personalized NeuroModulation and Its Effects on Sleep (DREAMS)

Major Depressive Disorder | Borderline Personality Disorder | Major Depressive Episode

Germany
University Hospital, Lille
Marc Sautelet Centre (Villeneuve d'Ascq, France)

Completed

Pressure Therapy in the Treatment of Upper Arm of Cerebral Palsy Children (PROPENSIX)

Cerebral Palsy

France
University of Florence
Sandro Gelsomino; Edvin Prifti; Francesco Cabrucci; Marco Bugetti; Orlando Parise; Aleksander...

Recruiting

Post-Surgery Extracorporeal Life Support (PC-ECLS)

Cardiogenic Shock | Extracorporeal Membrane Oxygenation Complication | Post-cardiac Surgery | Extracorporeal Life Support | Post Cardiac Arrest Syndrome

Italy
Università degli studi di Roma Foro Italico
Giuseppe Calcagno; Giovanni Fiorilli; Andrea Buonsenso; Marco Centorbi

Enrolling by invitation

Effect of WB-EMS on Parkinson's Disease

Parkinson Disease

Italy
Marc Sakwa, MD
Essential Pharmaceuticals, LLC

Completed

Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic Agent

Myocardial Ischemia | Heart Diseases | Coronary Artery Disease | Coronary Disease | Valvular Heart Disease

United States
Mario Negri Institute for Pharmacological Research
Papa Giovanni XXIII Hospital

Not yet recruiting

Medical Images Collection Research (MEDICALBUM)

Brain Diseases | Kidney Diseases

Italy
Mario Negri Institute for Pharmacological Research
University of Sydney; FightMND

Not yet recruiting

Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS (ALCALS)

Amyotrophic Lateral Sclerosis
National Cancer Institute, Naples
Mario Negri Institute for Pharmacological Research

Recruiting

Pembrolizumab With Chemotherapy in Front Line Advanced Ovarian, Primary Peritoneal and Fallopian Tube Cancer (MITO28MaNGOov4)

Ovarian Cancer

Italy
Mario Arpinati
European Commission

Recruiting

Multiple Donor Treg DLI for Severe Refractory Chronic GVHD (TREG2015001)

Chronic Graft Versus Host Disease

Italy
Universidad Peruana Cayetano Heredia
National University of San Marcos, Peru

Completed

Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru (Covid-Peru)

COVID-19

Peru
Mario Negri Institute for Pharmacological Research
Istituto Superiore di Sanità

Completed

Effects of Caloric Restriction in Obesity and Type 2 Diabetes (CRESO2)

Obesity | Type 2 Diabetes

Italy
Oncologia Medica dell'Ospedale Fatebenefratelli
Mario Negri Institute for Pharmacological Research

Completed

PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment

Metastatic Breast Cancer | Toxicity | Neurotoxicity | Adverse Drug Event | Drug Toxicity

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

MMF vs. AZA for Kidney Transplantation (ATHENA)

Kidney Transplant

Italy
Associazione Volontari Pazienti Oncologici
Mario Negri Institute for Pharmacological Research

Completed

Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck (H&N07)

Head and Neck Squamous Cell Carcinoma

Italy
Mario Negri Institute for Pharmacological Research
Agenzia Italiana del Farmaco

Completed

Rituximab in Multirelapsing Minimal Change Disease (MCD) or Focal Segmental Glomerulosclerosis (FSGS) (NEMO)

Nephrotic Syndrome

Italy
Associazione Progetto Oncologia UMAN.A
Mario Negri Institute for Pharmacological Research

Completed

Oxycodone and Pregabalin for the Treatment of Oncological Neuropathic Pain

Pain | Cancer

Italy

Clinical Trials Sponsored by Marco Bezzi

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Panama

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations